In September, the federal government announced Canada procured 20 million doses of the AstraZeneca-Oxford vaccine.
AstraZeneca said Monday that late-stage trials showed its coronavirus vaccine was up to nine per cent effective, giving public health officials hope they may soon have access to a vaccine that is cheaper and easier to distribute than some of its r...
'The biggest conversation now should be around planning,' said one expert.
The data suggests that those aged over 70, who are at higher risk of serious illness and death from COVID-19, could build robust immunity.
If it works, a vaccine would allow the world to return to some measure of normality after the tumult of the pandemic.